Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers
A Randomized, Open-Label, Single-Dose Bioavailability Study of SPARC001in Healthy, Adult Volunteers Under Fed and Fasted Conditions
Sponsor: Sun Pharma Advanced Research Company Limited
This PHASE1 trial investigates Healthy and is currently completed. Sun Pharma Advanced Research Company Limited leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2019 — Jan 2021 [monthly]
Completed PHASE1
-
Dec 2018 — Jun 2019 [monthly]
Completed PHASE1
▶ Show 6 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Completed PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE1
-
Oct 2017 — Mar 2018 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Jul 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE1
Status: Not Yet Recruiting → Active Not Recruiting
-
Feb 2017 — Jul 2017 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sun Pharma Advanced Research Company Limited
For direct contact, visit the study record on ClinicalTrials.gov .